Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells

Triple‐negative breast cancer (TNBC) faces significant treatment challenges due to its resistance to chemotherapy and high‐rate metastatic occurrence. Adjunctive treatment is a promising approach to improve chemotherapy effectiveness while reducing toxicity on normal cells. Natural compounds of Lans...

Full description

Saved in:
Bibliographic Details
Main Authors: Faaza Aulia Rahman, Aulia Nur Septiani, Desty Restia Rahmawati, Novia Permata Hapsari, Edy Meiyanto, Ratna Asmah Susidarti
Format: Article
Language:English
Published: Universitas Gadjah Mada, Yogyakarta 2025-03-01
Series:Indonesian Journal of Biotechnology
Subjects:
Online Access:https://jurnal.ugm.ac.id/ijbiotech/article/view/102112
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849732083643056128
author Faaza Aulia Rahman
Aulia Nur Septiani
Desty Restia Rahmawati
Novia Permata Hapsari
Edy Meiyanto
Ratna Asmah Susidarti
author_facet Faaza Aulia Rahman
Aulia Nur Septiani
Desty Restia Rahmawati
Novia Permata Hapsari
Edy Meiyanto
Ratna Asmah Susidarti
author_sort Faaza Aulia Rahman
collection DOAJ
description Triple‐negative breast cancer (TNBC) faces significant treatment challenges due to its resistance to chemotherapy and high‐rate metastatic occurrence. Adjunctive treatment is a promising approach to improve chemotherapy effectiveness while reducing toxicity on normal cells. Natural compounds of Lansium domesticum (duku) exhibit potential as adjunctive cancer treatments. This study aims to investigate the potential of duku peel extract (DPE) to be developed as an adjunctive agent. The cytotoxic activity of DPE against 4T1 cells was conducted through MTT assay, both in single and combination treatments. The anti‐migratory effect of DPE was examined by scratch wound healing assay. The molecular mechanism of DPE was confirmed using virtual screening via bioinformatics approaches, including protein target prediction and molecular docking. The results show that DPE has cytotoxic activity with an IC50 value of 47 µg/mL against the 4T1 cell line, in a 24‐hour treatment period. Interestingly, DPE not only had a good synergistic effect (mean CI value, i.e. 0.34), but also showed significant inhibition of cell migration with doxorubicin (Dox). Additionally, virtual bioinformatics screening approaches suggest the potential mechanism of DPE compound action by targeting CDC25B and TOP2A. Overall, DPE holds promise as an adjunctive treatment of Dox against 4T1 TNBC cells.
format Article
id doaj-art-69b8f2f6d64045a1a4e5e9d985007521
institution DOAJ
issn 0853-8654
2089-2241
language English
publishDate 2025-03-01
publisher Universitas Gadjah Mada, Yogyakarta
record_format Article
series Indonesian Journal of Biotechnology
spelling doaj-art-69b8f2f6d64045a1a4e5e9d9850075212025-08-20T03:08:20ZengUniversitas Gadjah Mada, YogyakartaIndonesian Journal of Biotechnology0853-86542089-22412025-03-0130110.22146/ijbiotech.10211237332Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cellsFaaza Aulia Rahman0Aulia Nur Septiani1Desty Restia Rahmawati2Novia Permata Hapsari3Edy Meiyanto4Ratna Asmah Susidarti5Cancer Chemoprevention Research Center (CCRC) Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, IndonesiaCancer Chemoprevention Research Center (CCRC) Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, IndonesiaCancer Chemoprevention Research Center (CCRC) Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, IndonesiaCancer Chemoprevention Research Center (CCRC) Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, IndonesiaLaboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, IndonesiaCancer Chemoprevention Research Center (CCRC) Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Indonesia; Laboratory of Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, IndonesiaTriple‐negative breast cancer (TNBC) faces significant treatment challenges due to its resistance to chemotherapy and high‐rate metastatic occurrence. Adjunctive treatment is a promising approach to improve chemotherapy effectiveness while reducing toxicity on normal cells. Natural compounds of Lansium domesticum (duku) exhibit potential as adjunctive cancer treatments. This study aims to investigate the potential of duku peel extract (DPE) to be developed as an adjunctive agent. The cytotoxic activity of DPE against 4T1 cells was conducted through MTT assay, both in single and combination treatments. The anti‐migratory effect of DPE was examined by scratch wound healing assay. The molecular mechanism of DPE was confirmed using virtual screening via bioinformatics approaches, including protein target prediction and molecular docking. The results show that DPE has cytotoxic activity with an IC50 value of 47 µg/mL against the 4T1 cell line, in a 24‐hour treatment period. Interestingly, DPE not only had a good synergistic effect (mean CI value, i.e. 0.34), but also showed significant inhibition of cell migration with doxorubicin (Dox). Additionally, virtual bioinformatics screening approaches suggest the potential mechanism of DPE compound action by targeting CDC25B and TOP2A. Overall, DPE holds promise as an adjunctive treatment of Dox against 4T1 TNBC cells.https://jurnal.ugm.ac.id/ijbiotech/article/view/102112adjunctive treatmentbioinformaticslansium domesticummigrationtnbc
spellingShingle Faaza Aulia Rahman
Aulia Nur Septiani
Desty Restia Rahmawati
Novia Permata Hapsari
Edy Meiyanto
Ratna Asmah Susidarti
Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
Indonesian Journal of Biotechnology
adjunctive treatment
bioinformatics
lansium domesticum
migration
tnbc
title Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
title_full Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
title_fullStr Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
title_full_unstemmed Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
title_short Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
title_sort duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4t1 cells
topic adjunctive treatment
bioinformatics
lansium domesticum
migration
tnbc
url https://jurnal.ugm.ac.id/ijbiotech/article/view/102112
work_keys_str_mv AT faazaauliarahman dukupeelethylacetateextractasanadjunctivetreatmentofdoxorubicinontriplenegativebreastcancer4t1cells
AT aulianurseptiani dukupeelethylacetateextractasanadjunctivetreatmentofdoxorubicinontriplenegativebreastcancer4t1cells
AT destyrestiarahmawati dukupeelethylacetateextractasanadjunctivetreatmentofdoxorubicinontriplenegativebreastcancer4t1cells
AT noviapermatahapsari dukupeelethylacetateextractasanadjunctivetreatmentofdoxorubicinontriplenegativebreastcancer4t1cells
AT edymeiyanto dukupeelethylacetateextractasanadjunctivetreatmentofdoxorubicinontriplenegativebreastcancer4t1cells
AT ratnaasmahsusidarti dukupeelethylacetateextractasanadjunctivetreatmentofdoxorubicinontriplenegativebreastcancer4t1cells